How big is Healthcare Triangle, Inc.?

As of Jun 18, Healthcare Triangle, Inc. has a market capitalization of 9.03 million, with net sales of 11.28 million and a net profit of -5.81 million over the last four quarters. The company reported shareholder's funds of -5.11 million and total assets of 1.96 million as of Dec 24.

Market Cap: As of Jun 18, Healthcare Triangle, Inc. has a market capitalization of 9.03 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 11.28 million and a net profit of -5.81 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company had shareholder's funds of -5.11 million and total assets of 1.96 million.

What does Healthcare Triangle, Inc. do?

Healthcare Triangle, Inc. is a micro-cap company in the Computers - Software & Consulting industry, reporting net sales of $4 million and a net loss of $2 million as of March 2025. It has a market cap of $9.03 million and key metrics indicating financial challenges, including a negative return on equity and no dividend yield.

Overview:<BR>Healthcare Triangle, Inc. operates in the Computers - Software & Consulting industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 9.03 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.71 <BR>Return on Equity: -67.70% <BR>Price to Book: 1.05 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Should I buy, sell or hold Healthcare Triangle, Inc.?

Is Healthcare Triangle, Inc. overvalued or undervalued?

As of November 23, 2021, Healthcare Triangle, Inc. is considered overvalued and risky due to negative financial metrics and a year-to-date return of -98.94%, significantly underperforming compared to the S&P 500's 12.22% gain.

As of 23 November 2021, Healthcare Triangle, Inc. moved from a grade of does not qualify to risky, indicating increased concerns about its valuation. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 0.31, an EV to EBIT of 0.71, and an EV to EBITDA of 0.87. In comparison to peers, Healthcare Triangle's valuation ratios are significantly worse; for instance, Cheche Group, Inc. has a P/E of -9.59 while NetSol Technologies, Inc. boasts a P/E of 39.42, highlighting the disparity in performance and valuation.<BR><BR>The company's stock has underperformed dramatically, with a year-to-date return of -98.94% compared to the S&P 500's positive return of 12.22%, reinforcing the notion that Healthcare Triangle is overvalued in its current state.

Is Healthcare Triangle, Inc. technically bullish or bearish?

As of August 12, 2025, Healthcare Triangle, Inc. shows a mixed technical outlook with a shift to mildly bullish on weekly indicators, despite significant underperformance with a year-to-date return of -98.94% compared to the S&P 500's 12.22%.

As of 12 August 2025, the technical trend for Healthcare Triangle, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also supports this view. However, the daily moving averages remain bearish, suggesting some short-term weakness. The KST shows a bullish signal on the weekly timeframe but is bearish monthly, and the Dow Theory reflects a mildly bullish stance weekly but mildly bearish monthly. Overall, the indicators present a mixed picture, with some suggesting bullish momentum while others indicate caution.<BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -98.94% versus the S&P 500's 12.22%. This stark contrast highlights the stock's ongoing struggles despite the recent shift in technical trend.